Primary Care Clinics in Duncan, SC Accepting Medicare
7 Primary Care Clinics found. Showing 1 - 7
 Chronic Health Solutions Llc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 Squires Pt Ste A, Duncan, SC 29334 Phone: 864-606-7764 |
Regenesis Organization Community Health Center Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 1663 E Main St, Duncan, SC 29334 Phone: 864-582-2411 Fax: 864-594-0040 |
Mary Black Physicians Group, Llc Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 500 Squire's Pointe, Duncan, SC 29334 Phone: 864-433-8980 Fax: 864-433-8982 |
Proactive Md Sc,p.a. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 245 Parkway E, Duncan, SC 29334 Phone: 864-501-0751 |
Squires Pointe Medical Park Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 Squires Pointe, Duncan, SC 29334 Phone: 864-433-8980 |
Medical Group Of The Carolinas - Family Medicine - Duncan Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1575 E Main Street, Duncan, SC 29334 Phone: 864-560-3500 Fax: 864-560-3522 |
Middle Tyger Family Medicine Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 Squires Pt, Suite B, Duncan, SC 29334 Phone: 864-433-8980 |
News Archive
Native Hawaiians have highest risk for pancreatic cancer, study shows
Native Hawaiians are at highest risk for pancreatic cancer, according to a USC study that provides a surprising look at disparities surrounding the deadly disease.
‘Soft' bipolar spectrum disorders differ from depression
The neurocognitive function of patients with major depression who fall into the "soft" bipolar spectrum resembles that of patients with bipolar II disorder rather than those with unipolar depression, say researchers.
Endomagnetics gets FDA's IDE approval to begin clinical trial of SentiMag and Sienna+ system
Cancer healthcare company Endomagnetics announced today that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration to initiate a pivotal clinical trial to evaluate the safety and effectiveness of the SentiMag and Sienna+ magnetic sentinel lymph node biopsy system in the management of breast cancer.
Metamark Genetics closes $22M Series B financing
Metamark Genetics, Inc., a molecular diagnostics company addressing a major challenge in cancer medicine, has completed a $22 million Series B financing. Metamark's Prognosis Determinants platform has illuminated the genetic drivers governing the lethal metastatic progression of major cancers and is now focused on pivotal translational and commercialization efforts to bring these breakthrough discoveries to cancer patients worldwide.
› Verified 4 days ago